BeiGene (NASDAQ:BGNE) Now Covered by Analysts at JMP Securities

JMP Securities began coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a research note released on Wednesday, Marketbeat reports. The firm issued a market outperform rating and a $288.00 price objective on the stock. Several other equities analysts also recently commented on the company. JPMorgan Chase & Co. upped their price objective on […]

Leave a Reply

Your email address will not be published.

Previous post Darden Restaurants (NYSE:DRI) PT Raised to $195.00 at Bank of America
Next post Smith Douglas Homes (NYSE:SDHC) PT Raised to $40.00